These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12057561)

  • 1. Does mucus hypersecretion matter in airway disease?
    Melton L
    Lancet; 2002 Jun; 359(9321):1924. PubMed ID: 12057561
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway mucus hypersecretion in asthma: an undervalued pathology?
    Rogers DF
    Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological blockade of the DP2 receptor inhibits cigarette smoke-induced inflammation, mucus cell metaplasia, and epithelial hyperplasia in the mouse lung.
    Stebbins KJ; Broadhead AR; Baccei CS; Scott JM; Truong YP; Coate H; Stock NS; Santini AM; Fagan P; Prodanovich P; Bain G; Stearns BA; King CD; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    J Pharmacol Exp Ther; 2010 Mar; 332(3):764-75. PubMed ID: 19996299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting airway mucus hypersecretion in chronic obstructive pulmonary disease.
    Tamaoki J
    Respir Investig; 2015 Nov; 53(6):247-8. PubMed ID: 26521101
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor.
    Zhu T; Zhang W; Wang DX; Huang NW; Bo H; Deng W; Deng J
    Chin Med J (Engl); 2012 Apr; 125(8):1457-64. PubMed ID: 22613653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anti-inflammatory effect of niflumic acid in gynaecological diseases].
    Legros R; Coiffard P
    Rev Fr Gynecol Obstet; 1973 Jun; 68(6):467-9. PubMed ID: 17474656
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of bronchial hypersecretion: recent studies.
    Pride NB
    Eur J Respir Dis Suppl; 1987; 153():13-8. PubMed ID: 3322856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucous hypersecretion and relationship to cough.
    Nadel JA
    Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological studies in mucus hypersecretion.
    Vestbo J
    Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation.
    Hoshino A; Tsuji T; Matsuzaki J; Jinushi T; Ashino S; Teramura T; Chamoto K; Tanaka Y; Asakura Y; Sakurai T; Mita Y; Takaoka A; Nakaike S; Takeshima T; Ikeda H; Nishimura T
    Int Immunol; 2004 Oct; 16(10):1497-505. PubMed ID: 15351784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis.
    Simpson JL; Phipps S; Gibson PG
    Pharmacol Ther; 2009 Oct; 124(1):86-95. PubMed ID: 19555716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic fluorine intoxication during prolonged treatment with niflumic acid].
    Gras-Champel V; Grados F; Fardellone P; Andréjak M
    Presse Med; 2003 Jun; 32(20):933. PubMed ID: 12876538
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
    Restrepo RD
    Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucus hypersecretion in the airway.
    Wang K; Wen FQ; Xu D
    Chin Med J (Engl); 2008 Apr; 121(7):649-52. PubMed ID: 18466687
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of disodium cromoglycate on airway mucus secretion during antigen-induced late asthmatic responses in a murine model of asthma.
    Koyama H; Tokuyama K; Nishimura H; Mizuno T; Mayuzumi H; Ohki Y; Arakawa H; Mochizuki H; Morikawa A
    Int Arch Allergy Immunol; 2005 Nov; 138(3):189-96. PubMed ID: 16205096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease].
    Park JA; Adler KB
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2890-2. PubMed ID: 17288783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.